The trademark application Boostrix was filed by GlaxoSmithKline Biologicals S.A., a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on April 21, 2002, and it was registered by office on November 25, 2002 without any oppositions.
The application was filed in English (French was selected as the second language).
Two renewals of the trademark were recorded, one on August 16, 2011, and the other one on April 14, 2021.
Change of name and address of the trademark registration was recorded on June 17, 2007. Change of name and professional address of the trademark registration was recorded on July 1, 2007. Appointment and Replacement of representative of the trademark registration was recorded on September 10, 2007. Appointment and Replacement of representative of the trademark registration was recorded on September 23, 2007. Appointment and Replacement of representative of the trademark registration was recorded on September 23, 2007. Relative errors of the trademark registration was recorded on February 20, 2012. Appointment and Replacement of representative of the trademark registration was recorded on May 26, 2016. Deletion of the representative of the trademark registration was recorded on January 6, 2021. Appointment and Replacement of representative of the trademark registration was recorded on February 22, 2021.